Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Joan Joseph-Munné"'
Autor:
Allisson Dantas de Oliveira, Carles Rubio Maturana, Francesc Zarzuela Serrat, Bruno Motta Carvalho, Elena Sulleiro, Clara Prats, Anna Veiga, Mercedes Bosch, Javier Zulueta, Alberto Abelló, Elisa Sayrol, Joan Joseph-Munné, Daniel López-Codina
Publikováno v:
PLoS ONE, Vol 19, Iss 6, p e0304085 (2024)
In a clinical context, conventional optical microscopy is commonly used for the visualization of biological samples for diagnosis. However, the availability of molecular techniques and rapid diagnostic tests are reducing the use of conventional micro
Externí odkaz:
https://doaj.org/article/be7683e99f3340b08fb6c52a0875f024
Autor:
Carles Rubio Maturana, Allisson Dantas de Oliveira, Sergi Nadal, Francesc Zarzuela Serrat, Elena Sulleiro, Edurne Ruiz, Besim Bilalli, Anna Veiga, Mateu Espasa, Alberto Abelló, Tomàs Pumarola Suñé, Marta Segú, Daniel López-Codina, Elisa Sayrol Clols, Joan Joseph-Munné
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
IntroductionMalaria is one of the most prevalent infectious diseases in sub-Saharan Africa, with 247 million cases reported worldwide in 2021 according to the World Health Organization. Optical microscopy remains the gold standard technique for malar
Externí odkaz:
https://doaj.org/article/32218ad0c42e4e38acb6d45a36012a74
Autor:
Carles Rubio Maturana, Allisson Dantas de Oliveira, Sergi Nadal, Besim Bilalli, Francesc Zarzuela Serrat, Mateu Espasa Soley, Elena Sulleiro Igual, Mercedes Bosch, Anna Veiga Lluch, Alberto Abelló, Daniel López-Codina, Tomàs Pumarola Suñé, Elisa Sayrol Clols, Joan Joseph-Munné
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Malaria is an infectious disease caused by parasites of the genus Plasmodium spp. It is transmitted to humans by the bite of an infected female Anopheles mosquito. It is the most common disease in resource-poor settings, with 241 million malaria case
Externí odkaz:
https://doaj.org/article/e266c8535f004d6d8672e486d8dac64b
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 8060 (2023)
Human papillomavirus (HPV) vaccines based on HPV L1 virus-like particles (VLPs) are already licensed but not accessible worldwide. About 38.0 million people were living with HIV in 2020 and there is no HIV vaccine yet. Therefore, safe, effective, and
Externí odkaz:
https://doaj.org/article/eaf371ed23894b19bb062aac4499c198
Publikováno v:
Vaccines, Vol 11, Iss 1, p 15 (2022)
In this study, the HIV-1 P18I10 CTL peptide derived from the V3 loop of HIV-1 gp120 and the T20 anti-fusion peptide of HIV-1 gp41 were inserted into the HPV16 L1 capsid protein to construct chimeric HPV:HIV (L1:P18I10 and L1:T20) VLPs by using the ma
Externí odkaz:
https://doaj.org/article/3c6cc2fcaa1c4af6b762cf1bbe56822b
Autor:
Esther Broset, Narcís Saubi, Núria Guitart, Nacho Aguilo, Santiago Uranga, Athina Kilpeläinen, Yoshiki Eto, Tomáš Hanke, Jesús Gonzalo-Asensio, Carlos Martín, Joan Joseph-Munné
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss , Pp 253-264 (2019)
The tuberculosis (TB) vaccine MTBVAC is the only live-attenuated Mycobacterium tuberculosis (Mtb)-based vaccine in clinical development, and it confers superior protection in different animal models compared to the current vaccine, BCG (Mycobacterium
Externí odkaz:
https://doaj.org/article/4a25bf7bef1a4aa7909cc3e9194b2412
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Prophylactic vaccines remain the best approach for controlling the human immunodeficiency virus-1 (HIV-1) transmission. Despite the limited efficacy of the RV144 trial in Thailand, there is still no vaccine candidate that has been proven successful.
Externí odkaz:
https://doaj.org/article/c39765f0ac964b99a55ff5e2c3a5312a
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1967 (2021)
Currently, three human papillomavirus (HPV) vaccines are already licensed and all of them are based on virus-like particles (VLPs) of HPV L1 capsid protein but not worldwide accessible. While about 38.0 million people were living with HIV in 2019, on
Externí odkaz:
https://doaj.org/article/4cf6175832534e679a66443b6624a38f
Autor:
Narcís Saubi, Athina Kilpeläinen, Yoshiki Eto, Chun-Wei Chen, Àlex Olvera, Tomáš Hanke, Christian Brander, Joan Joseph-Munné
Publikováno v:
Vaccines, Vol 8, Iss 4, p 678 (2020)
The use of Mycobacterium bovis bacillus Calmette–Guérin (BCG) as a live vaccine vehicle is a promising approach for HIV-1-specific T-cell induction. In this study, we used recombinant BCG expressing HIVACAT T-cell immunogen (HTI), BCG.HTI2auxo.int
Externí odkaz:
https://doaj.org/article/441eb8bbd5be41c5b9615ec5ac57520d
Autor:
Núria Guitart, Yoshiki Eto, Joan Joseph-Munné, Athina Kilpeläinen, Nacho Aguilo, Esther Broset, Tomáš Hanke, Carlos Martin, Narcís Saubi, Jesús Gonzalo-Asensio, Santiago Uranga
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss, Pp 253-264 (2019)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Molecular Therapy-Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss, Pp 253-264 (2019)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Molecular Therapy-Methods & Clinical Development
The tuberculosis (TB) vaccine MTBVAC is the only live-attenuated Mycobacterium tuberculosis (Mtb)-based vaccine in clinical development, and it confers superior protection in different animal models compared to the current vaccine, BCG (Mycobacterium